IP
ZOM

Isthmus Partners’s Zomedica Corp. ZOM Stock Holding History

Isthmus Partners’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-30,600
Closed -$6K – 144
2020
Q1 		$6K Sell
30,600
-33,600
-52% -$7.74K ﹤0.01% 136
2019
Q4 		$21K Buy
64,200
+22,200
+53% +$7.47K ﹤0.01% 139
2019
Q3 		$16K Buy
+42,000
New +$13K ﹤0.01% 138

Other funds holding ZOM

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JA
JVL Associates Wyoming, Michigan $352M AUM 27.55% 1-Year Est. Return

Isthmus Partners's ZOM Position: Q2 2020 in Review

Isthmus Partners sold out of Zomedica Corp. (ZOM) in Q2 2020, closing a stake of 30,600 shares — an estimated $6K sold.

Isthmus Partners first reported a position in ZOM in Q3 2019 and held it in 3 quarters. The position peaked at $21K in Q4 2019. 28 funds tracked by Wall St. Rank hold ZOM as of Q2 2020.

  • Isthmus Partners reported no remaining Zomedica Corp. position as of Q2 2020 after selling out during the quarter.
  • Isthmus Partners sold 30,600 Zomedica Corp. shares in Q2 2020, an estimated $6K.
  • Isthmus Partners first reported a position in Zomedica Corp. in Q3 2019 and held it in 3 quarters.
  • Isthmus Partners's Zomedica Corp. position peaked at $21K in Q4 2019.
  • 28 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2020.

Based on Isthmus Partners's 13F filing for Q2 2020, filed 10 Aug 2020.